ES2715005T3 - Extractos vegetales para mejorar la salud y la función cognitiva - Google Patents

Extractos vegetales para mejorar la salud y la función cognitiva Download PDF

Info

Publication number
ES2715005T3
ES2715005T3 ES13828399T ES13828399T ES2715005T3 ES 2715005 T3 ES2715005 T3 ES 2715005T3 ES 13828399 T ES13828399 T ES 13828399T ES 13828399 T ES13828399 T ES 13828399T ES 2715005 T3 ES2715005 T3 ES 2715005T3
Authority
ES
Spain
Prior art keywords
cognitive
memory
mice
acid
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13828399T
Other languages
English (en)
Spanish (es)
Inventor
Michael Ceddia
Kelli Herrlinger
Brandon Lewis
Harry Feng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemin Industries Inc
Original Assignee
Kemin Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries Inc filed Critical Kemin Industries Inc
Application granted granted Critical
Publication of ES2715005T3 publication Critical patent/ES2715005T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
ES13828399T 2012-08-09 2013-08-09 Extractos vegetales para mejorar la salud y la función cognitiva Active ES2715005T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261681414P 2012-08-09 2012-08-09
PCT/US2013/054274 WO2014026081A1 (en) 2012-08-09 2013-08-09 Plant extracts for improving cognitive health and function

Publications (1)

Publication Number Publication Date
ES2715005T3 true ES2715005T3 (es) 2019-05-31

Family

ID=50066333

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13828399T Active ES2715005T3 (es) 2012-08-09 2013-08-09 Extractos vegetales para mejorar la salud y la función cognitiva

Country Status (11)

Country Link
US (2) US20140044813A1 (OSRAM)
EP (1) EP2882443B1 (OSRAM)
JP (4) JP2015524484A (OSRAM)
KR (1) KR101947352B1 (OSRAM)
CN (2) CN111358832A (OSRAM)
AU (1) AU2013299491B2 (OSRAM)
BR (1) BR112015002739A2 (OSRAM)
CA (1) CA2880708C (OSRAM)
ES (1) ES2715005T3 (OSRAM)
PL (1) PL2882443T3 (OSRAM)
WO (1) WO2014026081A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160113277A (ko) * 2014-01-30 2016-09-28 케민 인더스트리즈, 인코포레이티드 인지 기능을 개선시키기 위한 식물 추출물
KR20170054501A (ko) * 2014-09-15 2017-05-17 케민 인더스트리즈, 인코포레이티드 인지 기능을 개선시키기 위한 식물 추출물
CN107105743A (zh) * 2014-10-08 2017-08-29 雅培制药有限公司 包含可氧化组分和水溶性植物提取物的营养组合物
ES2951079T3 (es) * 2016-11-11 2023-10-17 Kemin Ind Inc Uso de un extracto de menta verde para mejorar la tasa de neurogénesis
CN106727915B (zh) * 2017-01-18 2020-03-31 云南德彩堂生物医药科技有限公司 一种稳定高效提高记忆的组合物及其制备方法和应用
EP3703675A4 (en) * 2017-10-30 2021-06-16 Neuropore Therapies, Inc. SUBSTITUTED PHENYLSULFONYLPHÉNYLTRIAZOLETHIONES AND ASSOCIATED USES
CN109602759B (zh) * 2019-01-17 2020-10-09 广西医科大学 罗汉松实多糖的用途
KR102421772B1 (ko) * 2019-05-21 2022-07-18 건국대학교 글로컬산학협력단 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물
CN110463846A (zh) * 2019-07-30 2019-11-19 河南科技学院 留兰香提取物在制备抗宠物衰老药物或宠物食品中的应用
JP7330630B2 (ja) * 2019-11-20 2023-08-22 株式会社ニップン ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物
JP2022104122A (ja) * 2020-12-28 2022-07-08 株式会社ニップン オキシトシン関連シグナル活性化剤
CN120152704A (zh) * 2022-10-27 2025-06-13 凯敏工业公司 留兰香提取物在视网膜神经营养中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077715B1 (en) * 1998-05-16 2006-03-29 Mogam Biotechnology Research Institute Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
JP4629822B2 (ja) * 1999-12-02 2011-02-09 長瀬産業株式会社 神経成長因子合成促進剤
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
AU2006304787A1 (en) * 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP1925213A1 (en) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Dietary and pharmaceutical compositions comprising a sage extract comprising a mixture of tricyclic diterpenes and their derivatives and their uses
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
US20100137433A1 (en) * 2007-01-24 2010-06-03 Laima Kott Production of Rosmarinic Acid from Spearmint and uses Thereof
US7972633B2 (en) * 2007-02-07 2011-07-05 Applied Cognitive Sciences, LLC Nutritional supplements for healthy memory and mental function
EP2060192B9 (en) * 2007-10-17 2016-05-04 Rudolf Wild GmbH & Co. KG Composition comprising lemon balm extracts
CN102573865B (zh) * 2009-06-12 2016-08-24 基因雷克斯制药有限公司 用于预防和治疗红细胞聚集的组合物
CN101773488A (zh) * 2010-02-10 2010-07-14 青岛大学 一种基于迷迭香酸的药物及其在治疗帕金森病中的应用
JP2011256118A (ja) * 2010-06-07 2011-12-22 Kao Corp Ｉｌ−８及びｇｍ−ｃｓｆ発現抑制剤

Also Published As

Publication number Publication date
US20250009703A1 (en) 2025-01-09
US20140044813A1 (en) 2014-02-13
CN111358832A (zh) 2020-07-03
KR101947352B1 (ko) 2019-02-12
JP2015524484A (ja) 2015-08-24
BR112015002739A2 (pt) 2017-07-04
AU2013299491A1 (en) 2015-02-12
PL2882443T3 (pl) 2019-06-28
EP2882443A4 (en) 2016-01-06
CA2880708A1 (en) 2014-02-13
JP2025029029A (ja) 2025-03-05
AU2013299491B2 (en) 2018-03-15
JP2021066735A (ja) 2021-04-30
CA2880708C (en) 2023-09-26
CN104684562A (zh) 2015-06-03
EP2882443B1 (en) 2019-01-16
KR20150041654A (ko) 2015-04-16
EP2882443A1 (en) 2015-06-17
WO2014026081A1 (en) 2014-02-13
JP2023027232A (ja) 2023-03-01

Similar Documents

Publication Publication Date Title
ES2715005T3 (es) Extractos vegetales para mejorar la salud y la función cognitiva
Chaudhari et al. Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer's disease
Sharman et al. Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?
Smach et al. Effects of sage extract on memory performance in mice and acetylcholinesterase activity
Abu-Taweel et al. Pomegranate juice reverses AlCl3-Induced neurotoxicity and improves learning and memory in female mice
Abu-Taweel et al. Pomegranate juice rescues developmental, neurobehavioral and biochemical disorders in aluminum chloride-treated male mice
Schaffer et al. Plant foods and brain aging: a critical appraisal
Moradi Vastegani et al. Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson’s disease of male rats
Patel et al. Neuroprotective effect of lutein in scopolamine-induced Alzheimer’s disease in mice and zebrafish
Cho et al. Neuroprotective effects of Actinidia eriantha cv. Bidan kiwifruit on amyloid beta-induced neuronal damages in PC-12 cells and ICR mice
Khan et al. Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala
Shukla et al. Learning and memory enhancing activity of polyherbal formulation on streptozotocin induced memory impairment in rats via reducing mitochondria–targeted cytochrome
CA2838976C (en) Dha and epa in the reduction of oxidative stress
EP3461479A1 (en) Nutraceutical and pharmaceutical compositions, and uses thereof for preserving cognitive functions
AU2021204964A1 (en) Composition for use in the treatment of cognitive disorders
Marcos et al. Cognition and Omega-3 Fatty Acids-A Narrative Review of the Literature
Ghibhela et al. Chapter-3 Brahmi: A Memory Booster Medicinal Herb
Navarro Hortal Evaluation of redox-based bioactive compounds obtained from products and by-products of agri-food industry and beekeeping of interest in aging and aging-related diseases
Supriadi et al. Centella asiatica protect the development of aluminum-induced zebrafish larvae
Reddy Neuroprotective effects of Abelmoschus moschatus seed extract on fluoride-induced myelin degeneration in developing brain of rats
IT201800007640A1 (it) Composizione per prevenire o trattare forme di declino cognitivo
Puicǎ et al. PROTECTIVE EFFECTS OF A BIOACTIVE ANTIOXIDANT COMPLEX AGAINST ASPARTAME EXPOSURE DURING GESTATION. BIOCHEMICAL, MORPHOLOGICAL AND ULTRASTRUCTURAL STUDIES ON NEW-BORN RAT BRAIN.
Sharma TOXICITY INDUCED BY CONCURRENT EXPOSURE OF DIMETHOATE AND FLUORIDE AND ITS AMELIORATION BY ZINGIBER OFFICINALE
Faldu Neuropharmacological actions of Celastrus Paniculatus Wills
Ghrita impairment and oxidative stress in pentylenetetrazole induced seizures in rats